BNP Paribas Financial Markets trimmed its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 18.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 120,896 shares of the technology company's stock after selling 27,723 shares during the period. BNP Paribas Financial Markets owned 0.10% of Amdocs worth $10,576,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. First Horizon Advisors Inc. increased its position in Amdocs by 1.9% in the third quarter. First Horizon Advisors Inc. now owns 5,902 shares of the technology company's stock worth $516,000 after buying an additional 109 shares in the last quarter. Private Trust Co. NA raised its stake in Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after acquiring an additional 117 shares during the period. Natixis Advisors LLC raised its stake in Amdocs by 0.4% during the 2nd quarter. Natixis Advisors LLC now owns 27,246 shares of the technology company's stock worth $2,150,000 after acquiring an additional 120 shares during the period. Raymond James Trust N.A. lifted its holdings in Amdocs by 2.3% during the second quarter. Raymond James Trust N.A. now owns 5,796 shares of the technology company's stock valued at $457,000 after purchasing an additional 129 shares in the last quarter. Finally, Y.D. More Investments Ltd raised its position in shares of Amdocs by 1.5% during the 2nd quarter. Y.D. More Investments Ltd now owns 9,389 shares of the technology company's stock valued at $741,000 after purchasing an additional 139 shares during the period. 92.02% of the stock is owned by institutional investors.
Amdocs Trading Up 1.1 %
NASDAQ:DOX traded up $0.97 during midday trading on Monday, hitting $87.69. 502,234 shares of the company traded hands, compared to its average volume of 679,516. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. The firm's fifty day moving average is $88.08 and its 200-day moving average is $84.10. The firm has a market capitalization of $10.31 billion, a P/E ratio of 20.45, a P/E/G ratio of 1.45 and a beta of 0.74. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04.
Amdocs Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be issued a dividend of $0.479 per share. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.18%. Amdocs's payout ratio is 45.28%.
Analyst Ratings Changes
A number of equities research analysts have commented on DOX shares. Barclays decreased their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. StockNews.com cut Amdocs from a "strong-buy" rating to a "buy" rating in a report on Thursday, November 14th. Oppenheimer lifted their price objective on shares of Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. Finally, Stifel Nicolaus started coverage on shares of Amdocs in a research note on Wednesday, October 2nd. They set a "buy" rating and a $100.00 target price for the company. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $101.20.
Read Our Latest Research Report on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
